Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 25 , ISSUE 4 ( April, 2021 ) > List of Articles

EDITORIAL

Prevalence of Bloodstream Infections and their Etiology in COVID-19 Patients: A Tale of Two Cities

Niraj Tyagi

Citation Information : Tyagi N. Prevalence of Bloodstream Infections and their Etiology in COVID-19 Patients: A Tale of Two Cities. Indian J Crit Care Med 2021; 25 (4):355-357.

DOI: 10.5005/jp-journals-10071-23797

License: CC BY-NC 4.0

Published Online: 01-04-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Chiu YM, Chen DY. Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics. Expert Rev Clin Immunol 2020;16(2):207–228. DOI: 10.1080/1744666X.2019.1705785.
  2. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054–1062. DOI: 10.1016/S0140-6736(20)30566-3.
  3. Yap FHY, Gomersall CD, Fung KS, Ho PL, Ho OM, Lam PK, et al. Increase in methicillin-resistant Staphylococcus aureus acquisition rate and change in pathogen pattern associated with an outbreak of severe acute respiratory syndrome. Clin Infect Dis 2004;39(4):511–516. DOI: 10.1086/422641.
  4. Langford BL, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect 2020;26(12):1622–1629. DOI: 10.1016/j.cmi.2020.07.016.
  5. Feng Y, Ling Y, Bai T, Xie Y, Huang J, Li J, et al. COVID-19 with different severities: a multi-center study of clinical features. Am J Respir Crit Care Med 2020;201(11):1380–1388. DOI: 10.1164/rccm.202002-0445OC.
  6. Li J, Wang J, Yang Y, Cai P, Cao J, Cai X, et al . Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis. Antimicrob Resist Infect Control 2020;9(1):153. DOI: 10.1186/s13756-020-00819-1.
  7. Ripa M, Galli L, Poli A, Oltolini C, Spagnuolo V, Mastrangelo A, et al. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect 2020;27(3);451–457. DOI: 10.1016/j.cmi.2020.10.021.
  8. Li J, Cao J, Cai P, Shi B, Cao J, Zhang Y, et al. Risk factors of secondary infections in severe and critical patients hospitalized with COVID-19: a case-control study. Research Square 2021;1–9. DOI: 10.21203/rs.3.rs-55958/v1.
  9. Khurana S, Singh P, Sharad N, Kiro VV, Rastogi N, Lathwal A, et al. Profile of co-infections & secondary infections in COVID-19 patients at a dedicated COVID-19 facility of a tertiary care Indian hospital: implication on antimicrobial resistance. Indian J Med Microbiol 2020. DOI: 10.1016/j.ijmmb.2020.10.014.
  10. Rajni E, Garg VK, Bacchani D, Sharma R, Vohra R, Mamoria V, et al. Prevalence of bloodstream infections and their etiology in COVID-19 patients admitted in a Tertiary Care Hospital in Jaipur. Indian J Crit Care Med 2021;25(4):369–373.
  11. Sepulveda J, Westblade LF, Whittier S, Satlin MJ, Greendyke WG, Aaron JG, et al. Bacteremia and blood culture utilization during COVID-19 surge in New York city. J Clin Microbiol 2020;58(8):1–7. DOI: 10.1128/JCM.00875-20.
  12. Koehler P, Cornely OA, Bottiger BW, Dusse F, Eichenauer DA, Fuchs F, et al. COVID-19 associated pulmonary aspergillosis. Mycoses 2020;63(6):528–534. DOI: 10.1111/myc.13096.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.